IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.160
EU - Europa 1.983
AS - Asia 1.610
SA - Sud America 264
AF - Africa 29
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 8.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.079
PL - Polonia 610
CN - Cina 552
SG - Singapore 524
IT - Italia 334
DE - Germania 260
UA - Ucraina 245
BR - Brasile 236
HK - Hong Kong 212
FI - Finlandia 144
GB - Regno Unito 90
TR - Turchia 71
VN - Vietnam 68
IE - Irlanda 61
RU - Federazione Russa 59
CA - Canada 53
FR - Francia 43
IN - India 39
BD - Bangladesh 30
SE - Svezia 26
ID - Indonesia 25
NL - Olanda 25
EE - Estonia 23
MX - Messico 20
AR - Argentina 16
JP - Giappone 16
ZA - Sudafrica 16
ES - Italia 12
CZ - Repubblica Ceca 11
IQ - Iraq 11
AT - Austria 9
BE - Belgio 8
KG - Kirghizistan 8
LT - Lituania 8
AU - Australia 5
BG - Bulgaria 5
KR - Corea 5
LK - Sri Lanka 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CO - Colombia 4
NI - Nicaragua 4
PK - Pakistan 4
TW - Taiwan 4
EC - Ecuador 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
DZ - Algeria 2
KE - Kenya 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
GD - Grenada 1
IR - Iran 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.056
Salva come PNG Salva come JPEG
Città #
Warsaw 606
Fairfield 466
Ashburn 380
Woodbridge 328
Houston 279
Singapore 256
Chandler 241
Seattle 218
Hong Kong 192
Jacksonville 175
New York 172
Wilmington 165
Cambridge 143
Ann Arbor 128
Beijing 122
Los Angeles 112
Dearborn 106
Princeton 101
Helsinki 89
Brescia 83
Nanjing 63
Dublin 61
Munich 59
Istanbul 56
Dallas 47
Shanghai 45
Dong Ket 44
Milan 43
Des Moines 31
Buffalo 30
Chicago 30
São Paulo 30
Moscow 29
San Francisco 29
Toronto 25
London 24
The Dalles 24
Tallinn 23
Jakarta 22
San Diego 21
Redondo Beach 20
Shenyang 20
Jinan 19
Turku 19
Nanchang 18
Denver 17
Montreal 17
Tianjin 17
Brooklyn 15
Kunming 15
Phoenix 15
Santa Clara 15
Central 14
Changsha 14
Hangzhou 14
Johannesburg 14
Tokyo 14
Hebei 13
Nuremberg 13
Chennai 12
Jiaxing 12
Boston 10
Charlotte 10
Guangzhou 10
Monmouth Junction 10
Rome 10
Zhengzhou 10
Atlanta 9
Mexico City 9
Paris 9
Stockholm 9
Ankara 8
Belo Horizonte 8
Bishkek 8
Hanoi 8
Ho Chi Minh City 8
Lappeenranta 8
Poplar 8
Brussels 7
Falkenstein 7
Leawood 7
Manchester 7
Mumbai 7
Norwalk 7
Verona 7
Boardman 6
Miami 6
Orem 6
Pune 6
Rio de Janeiro 6
Brno 5
Council Bluffs 5
Curitiba 5
Hefei 5
Kilburn 5
Kyiv 5
Ningbo 5
Olomouc 5
Romola 5
Vienna 5
Totale 5.706
Salva come PNG Salva come JPEG
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 323
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 306
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 305
Claudin3 is localized outside the tight junctions in human carcinomas 270
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 257
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 198
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 188
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 183
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 182
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 177
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 175
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 175
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 170
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 167
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 164
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 163
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 163
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 161
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 158
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 157
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 156
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 148
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 148
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 146
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 145
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 138
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 130
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 129
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 125
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 124
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 120
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 119
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 115
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 112
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 110
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 109
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 104
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 100
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 97
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 95
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 95
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 95
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 88
Integrated mutational landscape analysis of uterine leiomyosarcomas 87
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 87
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 87
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 84
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 82
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 80
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 80
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 77
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 74
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 70
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 64
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 60
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 58
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 53
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 50
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 48
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 48
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 45
Finding the junction between claudins and endometrial carcinoma 41
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 36
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance 34
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 33
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 32
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 13
Totale 8.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021671 0 0 0 0 39 85 53 103 98 135 86 72
2021/2022544 64 92 11 3 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/20251.425 28 41 29 246 112 148 109 51 137 94 265 165
2025/20261.427 310 273 213 472 159 0 0 0 0 0 0 0
Totale 8.213